A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype
Completed · Phase 3 · Has a placebo group
Conditions studied: Asthma
In brief
This study will assess whether switching participants who have benefitted from mepolizumab or benralizumab to GSK3511294 (Depemokimab) is non-inferior to maintaining current treatment on the annualized rate of clinically significant exacerbations in participants with severe asthma with an eosinophilic phenotype. Throughout the study, all participants will continue their non-biologic Baseline standard of care (SoC) asthma treatment.
Key facts
- Study ID
- NCT04718389
- Run by
- GlaxoSmithKline
- People needed
- 1717
- Starts
- 2021-01-26
- Expected to finish
- 2025-09-14
- Last updated by the study team
- 2026-05-18
Who can join
Age: 12 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- GSK Investigational Site — Scottsboro, Alabama, United States
- GSK Investigational Site — Litchfield Park, Arizona, United States
- GSK Investigational Site — Phoenix, Arizona, United States
- GSK Investigational Site — Scottsdale, Arizona, United States
- GSK Investigational Site — Bakersfield, California, United States
- GSK Investigational Site — Encinitas, California, United States
- GSK Investigational Site — Huntington Beach, California, United States
- GSK Investigational Site — Los Angeles, California, United States
- GSK Investigational Site — Newport Beach, California, United States
- GSK Investigational Site — Oxnard, California, United States
- GSK Investigational Site — Rancho Cucamonga, California, United States
- GSK Investigational Site — Redondo Beach, California, United States
- GSK Investigational Site — Redwood City, California, United States
- GSK Investigational Site — Riverside, California, United States
- GSK Investigational Site — San Diego, California, United States
- GSK Investigational Site — San Diego, California, United States
- GSK Investigational Site — Valencia, California, United States
- GSK Investigational Site — Woodland, California, United States
- GSK Investigational Site — Aurora, Colorado, United States
- GSK Investigational Site — Colorado Springs, Colorado, United States
- GSK Investigational Site — Colorado Springs, Colorado, United States
- GSK Investigational Site — Denver, Colorado, United States
- GSK Investigational Site — Wheat Ridge, Colorado, United States
- GSK Investigational Site — New Haven, Connecticut, United States
- GSK Investigational Site — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.